fda warning compounded peptides bpc-157 tb-500 Next week, July 23-24, the FDA's Pharmacy Compounding Advisory Committee will review seven being considered for inclusion on the 503A Bulks List. Why does this matter? If these peptides are ultimately The FDA just announced that
Description
[1] The authors framed the observed metabolic shifts as a direct effect on lipid handling in the model rather than appetite suppression
Even more, those little buggers might be making things hurt elsewhere

Sunitinib in the treatment of advanced solid tumors
Oral supplements work as a slow climb
